The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
InnoCell is the brand name for Mitsui Chemicals’ cell culture products and services
WELIREG is the first and only oral hypoxia-inducible factor-2 alpha inhibitor approved in the European Union
_256_384.jpg)
Cipla's Lanreotide Injection is AP-rated therapeutic equivalent generic version of Somatuline Depot (Lanreotide) Injection
The FDA assigned a Prescription Drug User Fee Act (PDUFA) goal date of June 21, 2024
The drug will target specific genetic mutations prevalent in certain types of cancers
It is the first autotaxin inhibitor to be investigated in cancer patients
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Fluorouracil Injection is indicated for the treatment of patients with adenocarcinoma of colon and rectum and breast
Subscribe To Our Newsletter & Stay Updated
